Solstein Capital’s Cognizant CTSH Stock Holding History

Solstein Capital’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15	Closed	-$1K	–	356
2022 Q1	$1K	Hold	15	–	–	﹤0.01%	371
2021 Q4	$1K	Hold	15	–	–	﹤0.01%	408
2021 Q3	$1K	Hold	15	–	–	﹤0.01%	448
2021 Q2	$1K	Buy	+15	New	+$1.12K	﹤0.01%	429

Other funds holding CTSH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Solstein Capital's CTSH Position: Q2 2022 in Review

Solstein Capital sold out of Cognizant (CTSH) in Q2 2022, closing a stake of 15 shares — an estimated $1K sold.

Solstein Capital first reported a position in CTSH in Q2 2021 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 916 funds tracked by Wall St. Rank hold CTSH as of Q2 2022.

Solstein Capital reported no remaining Cognizant position as of Q2 2022 after selling out during the quarter.
Solstein Capital sold 15 Cognizant shares in Q2 2022, an estimated $1K.
Solstein Capital first reported a position in Cognizant in Q2 2021 and held it in 4 quarters.
Solstein Capital's Cognizant position peaked at $1K in Q1 2022.
916 funds tracked by Wall St. Rank held Cognizant as of Q2 2022.

Based on Solstein Capital's 13F filing for Q2 2022, filed 9 Aug 2022.